X @Bloomberg
Bloomberg·2025-07-10 14:51
A unit of Glenmark Pharmaceuticals has entered into a pact with AbbVie to license its multiple myeloma drug that’s under development for an upfront payment of $700 million https://t.co/TVv4IcdQ6L ...
A unit of Glenmark Pharmaceuticals has entered into a pact with AbbVie to license its multiple myeloma drug that’s under development for an upfront payment of $700 million https://t.co/TVv4IcdQ6L ...